TERT promoter mutations were assessed in baseline urine samples (1.9–4.5 mL) from 38 individuals who subsequently developed primary BC and 152 matched controls using the UroMuTERT and droplet digital PCR assays. The gene discussed is TERT; the disease is breast cancer.